Detalles de la búsqueda
1.
Meaningful Change Thresholds and Fatigue Severity Points on Patient-Reported Outcomes by the Fatigue Symptoms and Impacts Questionnaire in Patients With Relapsing Multiple Sclerosis.
Value Health;
27(5): 598-606, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38401796
2.
Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey.
BMC Psychiatry;
22(1): 187, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35300629
3.
Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review.
BMC Neurol;
21(1): 468, 2021 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34856949
4.
Shared Decision-Making in the Treatment of Multiple Sclerosis: Results of a Cross-Sectional, Real-World Survey in Europe and the United States.
Patient Prefer Adherence;
18: 137-149, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249686
5.
Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment.
Patient;
2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748388
6.
Severity and worsening of fatigue among individuals with multiple sclerosis.
Mult Scler J Exp Transl Clin;
9(2): 20552173231167079, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101754
7.
Feasibility study to evaluate capabilities for conducting psychiatric clinical research within the Rwandan mental healthcare system.
BMJ Open;
13(4): e064675, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37072361
8.
Comparative Efficacy of Relapsing Multiple Sclerosis Therapies: Model-Based Meta-Analyses for Confirmed Disability Accumulation and Annualized Relapse Rate.
Mult Scler Relat Disord;
64: 103908, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803162
9.
Comparing Relapse Rates in Real-World Patients with Schizophrenia Who Were Adequately versus Not Adequately Treated with Paliperidone Palmitate Once-Monthly Injections Before Transitioning to Once-Every-3-Months Injections.
Neuropsychiatr Dis Treat;
18: 1927-1937, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36065384
10.
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.
Patient Prefer Adherence;
15: 2239-2248, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34629867
11.
Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States.
Front Psychiatry;
12: 695672, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34764891
12.
Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire.
Patient Prefer Adherence;
14: 1093-1102, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32753849
13.
Ethical and Social Implications of Using Predictive Modeling for Alzheimer's Disease Prevention: A Systematic Literature Review.
J Alzheimers Dis;
76(3): 923-940, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32597799
14.
Ethical and social implications of using predictive modeling for Alzheimer's disease prevention: a systematic literature review protocol.
BMJ Open;
9(3): e026468, 2019 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833325
Resultados
1 -
14
de 14
1
Próxima >
>>